🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to continue our fellow's ASCO YIA grant writing workshop, now as a collaborative effort between Penn Medicine - Abramson Cancer Center and for the first time so far, UTSW Simmons Cancer Center . Ronac Mamtani gets the credit for leading this effort. Lets hope we can inspire the next gen of cancer researchers

Great to see Ronac Mamtani Karine Tawagi MD moderating oral rapid abstract session!Watching with KSridhar Neeraj Agarwal, MD, FASCO who is tweeting real time..interesting data on ACC & chromophobe RCC! Martin Voss great Q&A! ASCO #ASCO24 OncoAlert Sumanta K. Pal, MD, FASCO Toni Choueiri, MD Laurence Albiges Pavlos Msaouel

Co-chair session with Ronac Mamtani ✅ w/ good data on rarer GU tumors: 🌀Metastatic urachal: 1L FOLFIRINOX ORR 62%, PFS 9.3mo, OS 19.7mo 🌀Metastatic ACC: 2L caremlizumab + apatinib ORR 52% PFS 12.6mo, OS 20.9mo 🌀Metastatic chromophobe RCC: doublet > singlet

G.O.A.T Lynn Schuchter Angie DeMichele, MD, MSCE, FASCO Charu Aggarwal, MD, MPH, FASCO ASCO

Amazing women in GU chaired the bladder-kidney session yesterday — stellar work from friends Suzanne Cole, MD, FACP, FASCO & Maite Bourlon! UTSW Simmons Cancer Center UTSW Hematology & Oncology #ASCO24 ASCO

Thank you UroToday.com for highlighting our work with Ronac Mamtani Jean Hoffman-Censits and Vivek Nimgaonkar on Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin urotoday.com/recent-abstrac…

We've had no data on real-world EV+P use for mUC, until now. In European Urology we show rapid dissemination of EV+P in practice. As of 3/31/24, <4 mo after U.S. FDA full approval, EV+P accounted for ~50% of 1L tx starts, supplanting platinum-chemo (23%). authors.elsevier.com/a/1jeFg14kplyy…

Thanks Ronac Mamtani for this incredibly timely submission to European Urology. Amazing to see how rapidly the data Tom Powles presented last year at #ESMO23 is impacting clinical practice. Alberto Briganti Andrea Necchi Petros Grivas Uromigos Sarah P. Psutka MD MS Laura Bukavina

ICYMI from our 2024 Impact Report: Implementing a text message symptom reporting tool to reduce "time toxicity" saved pts w/ advanced cancer 66 minutes per encounter. Led by Erin Bange MD MSCE & Ronac Mamtani More on TIME: pc3i.upenn.edu/our-work/proje… Impact Report: pc3i.upenn.edu/app/uploads/20…

In JNCI Penn Medicine - Abramson Cancer Center Jake Reibel quantifies impacts of nationwide platinum shortages on prescribing & mortality in U.S. pts w/cancer. Rx rates for cis/carbo fell 15% at peak, but no diff. in mortality (HR 1.00, 0.94-1.07), during vs before shortage. bit.ly/3D9SheV

An article published in JNCI, led by Jacob Reibel, MD & PC3I Faculty Ronac Mamtani, showed that short-term mortality was not impacted for patients with advanced cancers during 2023's platinum chemo shortage. Read the news release from Penn Medicine: pennmedicine.org/news/news-rele…

The champ is here ! Dr David Vaughn’s famous ( and final ) testis cancer lecture. Penn Urology Lynn Schuchter Charu Aggarwal, MD, MPH, FASCO Ravi B. Parikh Phillip Pierorazio Ruchika Talwar Thank you Dave, for > three decades of inspiration Penn Medicine - Abramson Cancer Center #lastdance

One of the hardest things I do in #oncology clinic is translate results from a clinical trial to the #patient in front of me. In Nature Medicine, we introduce TrialTranslator, a #machinelearning framework for individualized #cancer trial emulation. nature.com/articles/s4159…

TrialTranslator - a machine learning framework for individualized cancer trial emulation - Ravi B. Parikh oncodaily.com/url/218402 Nature Medicine Qi Long Ronac Mamtani #Cancer #MachineLearning #ClinicalTrial #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

On Jan. 31, Penn Men's Basketball hosted their annual Coaches vs. Cancer game against Brown. Our own medical oncologist, Ronac Mamtami, MD, was honored as the Penn Medicine Employee of the Game. Congratulations, Dr. Mamtani! Ronac Mamtani #BladderCancer

Finally...a study on how to reduce time toxicity, rather than another study that quantifies it. Led by Erin Bange MD MSCE supported by Conquer Cancer, the ASCO Foundation Penn Cancer Innovation Tim Brown, MD MSCE kerrycoughlin.bsky.social Carmen Guerra Lynn Schuchter Penn Medicine - Abramson Cancer Center

A new NEJM Catalyst study highlights a text messaging platform that addresses “time toxicity” for #cancer patients, saving more than 1 hour per visit. Penn Medicine - Abramson Cancer Center Ronac Mamtani spr.ly/6013I4CI1

A study published in NEJM Catalyst & led by Erin Bange MD MSCE & PC3I Faculty Ronac Mamtani found that implementing a text message-based symptom reporting e-triage saved patients with #cancer 30 minutes in wait time and 66 minutes in total care time. pc3i.upenn.edu/news/text-mess…

5 articles suggested by Wafik El-Deiry Wafik S. El-Deiry, MD, PhD, FACP oncodaily.com/blog/wafik-el-… Authors: Richarda de Voer Erin Bange MD MSCE Ronac Mamtani Vinod BalachandranMD Pablo Guasp #Cancer #CancerResearch #Medicine #Health #MedEd #MedX #MedNews #CancerTreatment #Oncology #OncoDaily

This team ASCO headquarters was super efficient today! Was a privilege planning the kidney-bladder track w Rana McKay, MD, FASCO Tom Powles Ronac Mamtani David Braun #ManuelaSchmidinger Liza Henry McDonald & chair Peter Black ! #ASCO25